Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

Judy Kurtz chats with The Hill’s congressional reporter Mychael Schnell about President Trump saying he wants to “help” Mexico and Canada with his delay of some tariffs against Canada and Mexico until ...

Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...

Global Active Pharmaceutical Ingredients Market is valued at USD 155.2 Billion in 2023. Global Active Pharmaceutical Ingredients Market valuation to reach USD 314.24 Billion by 2032. Active ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. Let's figure out ...

It was FDA approved based on a clinical trial that showed it, overall, delayed the onset of insulin dependence from two years ...

Lexaria executing a triple-pronged strategy in obesity and diabetesSemaglutide recently approved to treat chronic kidney disease KELOWNA, BC / ACCESS Newswire / February 27, 2025 / Lexaria Bioscience ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

The fourth single lifted from the band's self-titled debut album Five, Everybody Get Up comes in at Number 3 on the lift; shifting a total of 465,000 chart units to date. At the time, it earned ...